Trial intelligence / Profile preview

Vaginal estradiol addition for luteal support in GnRH antagonist IVF/ICSI cycles

ChiCTR1900022631Phase 4Recruiting

Sponsor
Women's Hospital, Zhejiang University School of Medicine
Start
Apr 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of estradiol, progesterone and dydrogesterone in female infertility (2 arms), sponsored by Women's Hospital, Zhejiang University School of Medicine. Primary endpoint: ongoing pregnancy. Started Apr 2019; status: recruiting.

02

Drugs

estradiolprogesteronedydrogesterone
03

Conditions

female infertility

Beyond the preview

Go deeper on ChiCTR1900022631.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900022631.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call